Category: Approval/Launch Region: Europe · United Kingdom Company: Astrazeneca Ltd

EMA committee recommends approval of AstraZenecas Forxiga for symptomatic chronic heart failure

EMA committee recommends approval of AstraZenecas Forxiga for symptomatic chronic heart failure
AstraZeneca

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!